Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Thomas Forst & Andreas Pfützner. (2013) Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitus. Expert Review of Endocrinology & Metabolism 8:1, pages 21-35.
Read now
Read now
Sherwyn L. Schwartz. (2012) Saxagliptin for the treatment of type 2 diabetes mellitus: Focus on recent studies. Annals of Medicine 44:2, pages 157-169.
Read now
Read now
Articles from other publishers (5)
Biljana Vujcic, Jessica Wyllie, Tania, Jed Burns, Keith F. White, Simon Cromwell, David W. Lupton, Jason L. Dutton, Tatiana P. Soares da Costa & Sevan D. Houston. (2023) Cage hydrocarbons as linkers in dimeric drug design: Case studies with trimethoprim and tedizolid. Bioorganic & Medicinal Chemistry Letters 80, pages 129086.
Crossref
Crossref
Sevan D. Houston, Benjamin A. Chalmers, G. Paul Savage & Craig M. Williams. (2019)
Enantioselective synthesis of (
R
)-2-cubylglycine including unprecedented rhodium mediated C–H insertion of cubane
. Organic & Biomolecular Chemistry 17:5, pages 1067-1070.
Crossref
Crossref
R.C.L. Page. 2014. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
763
787
.
R.C.L. Page. 2012. A worldwide yearly survey of new data in adverse drug reactions and interactions. A worldwide yearly survey of new data in adverse drug reactions and interactions
685
702
.
C. G. Patel, D. Kornhauser, N. Vachharajani, B. Komoroski, E. Brenner, M. Handschuh del Corral, L. Li & D. W. Boulton. (2011) Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjects. Diabetes, Obesity and Metabolism 13:7, pages 604-614.
Crossref
Crossref